CalciMedica, Inc. announced that it has entered into a securities purchase agreement to issue an aggregate of 5,113,812 shares at a price of $3.70 per share for the gross proceeds of $18,921,104 and pre funded warrants for the gross proceeds of $1,478,896 for an aggregate proceeds of $20,400,000 on January 19, 2024. The warrants will be exercisable into common shares at an exercise price of $0.0001. The transaction will be closed in two tranches on with the initial closing expected on January 23, 2024 and the second closing expected on February 5, 2024, in each case, subject to customary closing conditions.

As a part of the transaction, the company may pay a transaction fee of up to 5.00% of the aggregate gross proceeds of each closing of the Private Placement, payable in cash and/or, upon mutual agreement. In addition, the Company agreed to pay certain expenses of agent to purchase up to an aggregate of 70,241 shares of Common Stock at the initial closing of the Private Placement and 8,108 shares of Common stock at the second closing of the private placement, in each case, at an exercise price equal to $0.0001 per share.